FindTrial
Sign In

Cinacalcet hydrochloride

DRUG5 trials

Sponsors

Kobe University School of Medicine, St Marianna University, Wake Forest University Health Sciences, Amgen, Kyowa Kirin Co., Ltd.

Conditions

Adenocarcinoma of the ProstateChronic Kidney DiseaseHypercalcemia with persistent hyperparathyroidism in renal transplant recipients.Hyperparathyroidism, SecondaryRecurrent Prostate CancerSecondary HyperparathyroidismSecondary hyperparathyroidism

Phase 2

Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer
CompletedNCT01054079
Wake Forest University Health SciencesAdenocarcinoma of the Prostate, Recurrent Prostate Cancer
Start: 2011-09-30End: 2014-08-31Updated: 2018-07-05
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
TerminatedNCT01439867
AmgenChronic Kidney Disease, Hyperparathyroidism, Secondary
Start: 2012-06-22End: 2016-06-03Updated: 2020-06-17

Phase 3

Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia
CompletedNCT03822507
Kyowa Kirin Co., Ltd.Secondary Hyperparathyroidism
Start: 2019-04-09End: 2021-09-23Updated: 2022-04-25

Unknown Phase

Effect of cinacalcet hydrochloride on oxidative stress in patients with secondary hyperparathyroidism
Active, not recruitingJPRN-UMIN000002523
Kobe University School of MedicineSecondary hyperparathyroidism
Start: 2009-10-01Target: 10Updated: 2026-06-29
Cinacalcet for the treatment of hypercalcemia with persistent hyperparathyroidism in renal transplant recipients: a case siries study.
Active, not recruitingJPRN-UMIN000003236
St Marianna UniversityHypercalcemia with persistent hyperparathyroidism in renal transplant recipients.
Start: 2010-03-01Target: 15Updated: 2026-06-29